Cargando…

Diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion

BACKGROUND: Pleural effusion (PE) is presenting symptoms of many different diseases and is often a diagnostic challenge. Negative cytology in the malignant PE requires more complicated diagnostic procedures, such as closed pleural biopsy or thoracoscopic pleural biopsy. Not all the patients will be...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnan, Vishnu G, Kunoor, Akhilesh, Keechilath, Pavithran, Mehta, Asmita Anilkumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098895/
https://www.ncbi.nlm.nih.gov/pubmed/33687007
http://dx.doi.org/10.4103/lungindia.lungindia_196_20
_version_ 1783688496381165568
author Krishnan, Vishnu G
Kunoor, Akhilesh
Keechilath, Pavithran
Mehta, Asmita Anilkumar
author_facet Krishnan, Vishnu G
Kunoor, Akhilesh
Keechilath, Pavithran
Mehta, Asmita Anilkumar
author_sort Krishnan, Vishnu G
collection PubMed
description BACKGROUND: Pleural effusion (PE) is presenting symptoms of many different diseases and is often a diagnostic challenge. Negative cytology in the malignant PE requires more complicated diagnostic procedures, such as closed pleural biopsy or thoracoscopic pleural biopsy. Not all the patients will be fit for such invasive procedures due to high risk. Tumor markers seem to be a promising alternative and have been proposed to aid in the differentiation of the PE etiology. OBJECTIVE: The objective of the study was to evaluate the diagnostic value of pleural fluid carcinoembryonic antigen (CEA) in differentiation between malignant and nonmalignant PEs and to compare adenosine deaminase (ADA) levels with respect to malignant and nonmalignant PE. METHODOLOGY: It was a prospective observational study. Patients who presented with undiagnosed exudative PE during the time period 2016–2018 were studied. Pleural fluid was subjected to all routine investigations such as sugar, protein, lactate dehydrogenase, ADA, and CEA. RESULTS: A total of 100 patients were included in the study. Fifty-one patients had malignancy. Univariate analysis showed that smoker, previous history of cancer, ADA <20, and CEA of >2.15 were variables associated with malignancy. Multivariate analysis showed pleural fluid CEA >2.15 as only independent risk factor associated with malignancy. The sensitivity of 91.5% and 65% and specificity of 92.5% and 81.4%, respectively, were found for CEA 2.15 ng/dl and ADA <16.5 U/L as plotted from receiver operating characteristic curve. The combined CEA and ADA (2.39 ng/ml and 16.5 U/L) values in pleural fluid had higher sensitivity of 100%. CONCLUSION: Our study demonstrated that pleural fluid CEA levels have a sensitivity of 93.5% and specificity of 73% in diagnosing of malignant PE. ADA levels lesser than 16.5 U/L were seen in patients with malignant PE, but less sensitive and specific compared to CEA. Combined ADA and CEA levels had higher sensitivity than CEA alone.
format Online
Article
Text
id pubmed-8098895
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-80988952021-05-07 Diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion Krishnan, Vishnu G Kunoor, Akhilesh Keechilath, Pavithran Mehta, Asmita Anilkumar Lung India Original Article BACKGROUND: Pleural effusion (PE) is presenting symptoms of many different diseases and is often a diagnostic challenge. Negative cytology in the malignant PE requires more complicated diagnostic procedures, such as closed pleural biopsy or thoracoscopic pleural biopsy. Not all the patients will be fit for such invasive procedures due to high risk. Tumor markers seem to be a promising alternative and have been proposed to aid in the differentiation of the PE etiology. OBJECTIVE: The objective of the study was to evaluate the diagnostic value of pleural fluid carcinoembryonic antigen (CEA) in differentiation between malignant and nonmalignant PEs and to compare adenosine deaminase (ADA) levels with respect to malignant and nonmalignant PE. METHODOLOGY: It was a prospective observational study. Patients who presented with undiagnosed exudative PE during the time period 2016–2018 were studied. Pleural fluid was subjected to all routine investigations such as sugar, protein, lactate dehydrogenase, ADA, and CEA. RESULTS: A total of 100 patients were included in the study. Fifty-one patients had malignancy. Univariate analysis showed that smoker, previous history of cancer, ADA <20, and CEA of >2.15 were variables associated with malignancy. Multivariate analysis showed pleural fluid CEA >2.15 as only independent risk factor associated with malignancy. The sensitivity of 91.5% and 65% and specificity of 92.5% and 81.4%, respectively, were found for CEA 2.15 ng/dl and ADA <16.5 U/L as plotted from receiver operating characteristic curve. The combined CEA and ADA (2.39 ng/ml and 16.5 U/L) values in pleural fluid had higher sensitivity of 100%. CONCLUSION: Our study demonstrated that pleural fluid CEA levels have a sensitivity of 93.5% and specificity of 73% in diagnosing of malignant PE. ADA levels lesser than 16.5 U/L were seen in patients with malignant PE, but less sensitive and specific compared to CEA. Combined ADA and CEA levels had higher sensitivity than CEA alone. Wolters Kluwer - Medknow 2021 2021-03-02 /pmc/articles/PMC8098895/ /pubmed/33687007 http://dx.doi.org/10.4103/lungindia.lungindia_196_20 Text en Copyright: © 2021 Indian Chest Society https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Krishnan, Vishnu G
Kunoor, Akhilesh
Keechilath, Pavithran
Mehta, Asmita Anilkumar
Diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion
title Diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion
title_full Diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion
title_fullStr Diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion
title_full_unstemmed Diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion
title_short Diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion
title_sort diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098895/
https://www.ncbi.nlm.nih.gov/pubmed/33687007
http://dx.doi.org/10.4103/lungindia.lungindia_196_20
work_keys_str_mv AT krishnanvishnug diagnosticutilityofpleuralfluidcarcinoembryonicantigeninpatientswithexudativepleuraleffusion
AT kunoorakhilesh diagnosticutilityofpleuralfluidcarcinoembryonicantigeninpatientswithexudativepleuraleffusion
AT keechilathpavithran diagnosticutilityofpleuralfluidcarcinoembryonicantigeninpatientswithexudativepleuraleffusion
AT mehtaasmitaanilkumar diagnosticutilityofpleuralfluidcarcinoembryonicantigeninpatientswithexudativepleuraleffusion